Tryp Therepeutics Inc. (OTCQB: TRYPF) is a pharmaceutical company focused on developing psilo-cybin-based compounds to treat diseases with unmet medical needs through accelerated regulatory pathways. CEO and Chief Scientific Officer joins us to discuss the company's drug development programs and the types of disorders it's currently targeting.

View Podcast Transcript